12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, health care stocks saw significant movement. MorphoSys, Modular Medical, Akso Health Group, Assure Hldgs, Gain Therapeutics, and Societal CDMO were among the gainers, with increases ranging from 11.49% to 15.1%. Conversely, Allakos, Accelerate Diagnostics, Atreca, Evaxion Biotech, Inventiva, and Akanda were the losers, with declines between 10.64% and 56.5%.
January 16, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's stock increased by 14.01% to $1.22, with a market value of $27.8 million.
The stock's pre-market increase may lead to a short-term positive trend, reflecting investor optimism.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
Gain Therapeutics shares increased by 13.75% to $3.97, with a market value of $64.3 million.
The pre-market gain could suggest a bullish short-term outlook for the stock, driven by investor confidence.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Assure Hldgs shares moved up by 13.82% to $0.28, with a market cap of $1.8 million.
The upward movement in pre-market may indicate short-term investor interest and potential price growth.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Modular Medical's shares rose 14.45% to $1.9, with a market cap of $40.4 million.
The pre-market rise indicates a positive short-term outlook for the stock, potentially due to investor confidence.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
MorphoSys shares surged 15.1% in pre-market trading, with a market cap of $1.4 billion.
The significant pre-market gain suggests positive investor sentiment which could lead to a short-term price increase.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Societal CDMO stock rose 11.49% to $0.39, with a market cap of $40.6 million.
The increase in pre-market trading suggests a positive short-term sentiment which may lead to price appreciation.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Akanda stock declined by 10.64% to $0.42, with a market value of $1.6 million.
The pre-market drop suggests potential short-term bearishness, possibly due to investor concerns or negative news.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEGATIVE IMPACT
Allakos stock plummeted 56.5% to $1.3 in pre-market trading, with a market cap of $113.7 million.
The substantial pre-market drop is a strong indicator of negative investor sentiment, likely leading to a short-term decline in stock price.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 95
NEGATIVE IMPACT
Accelerate Diagnostics shares fell 16.22% to $3.1, with a market cap of $45.1 million.
The pre-market decline suggests a bearish outlook for the stock in the short term, reflecting negative market sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 85
NEGATIVE IMPACT
Atreca stock declined by 14.88% to $0.3, with a market value of $12.0 million.
The significant pre-market drop may lead to a short-term negative price trend, possibly due to investor skepticism.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
NEGATIVE IMPACT
Evaxion Biotech shares decreased by 13.65% to $0.69, with a market cap of $26.1 million.
The drop in pre-market trading indicates a bearish sentiment that could negatively affect the stock's short-term performance.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Inventiva shares decreased by 12.42% to $3.88, with a market cap of $200.3 million.
The pre-market decline could be a precursor to a short-term downtrend, reflecting a lack of investor confidence.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80